## ğŸ“ Research Question (PICO) | ç ”ç©¶å•é¡Œ

- **P**opulation (æ—ç¾¤): 
- **I**ntervention (ä»‹å…¥): 
- **C**omparison (æ¯”è¼ƒ): 
- **O**utcome (çµæœ): 

---

## ğŸ“ Eligibility Criteria | ç´å…¥æ’é™¤æ¢ä»¶ âš ï¸ REQUIRED

### Inclusion Criteria | ç´å…¥æ¢ä»¶
- Study design: [RCT only / RCT + observational / etc.]
- Population: 
- Intervention: 
- Outcome reported: 
- Language: [English only / No restriction]
- Publication period: 

### Exclusion Criteria | æ’é™¤æ¢ä»¶
- 
- 
- 

---

## ğŸ“ Search Strategy | æœå°‹ç­–ç•¥ âš ï¸ REQUIRED

### Databases | è³‡æ–™åº«
- [ ] PubMed/MEDLINE
- [ ] Embase
- [ ] Cochrane Library
- [ ] Web of Science
- [ ] Other: 

### Search Terms | æœå°‹è©
```
(term1 OR term2) AND (term3 OR term4) AND (term5)
```

### Grey Literature | ç°è‰²æ–‡ç»
- [ ] ClinicalTrials.gov
- [ ] Conference abstracts
- [ ] Reference lists
- [ ] Expert consultation

---

## ğŸ“ Study Selection | æ–‡ç»ç¯©é¸

### Screening Process | ç¯©é¸æµç¨‹
- **Title/Abstract screening**: [Independent / Dual]
- **Full-text review**: [Independent / Dual]
- **Discrepancy resolution**: [Third reviewer / Consensus]

### PRISMA Flow | PRISMA æµç¨‹åœ–
> [Will be generated after search]

---

## ğŸ“ Data Extraction | è³‡æ–™æ“·å–

### Variables to Extract | æ“·å–è®Šæ•¸
| Category | Variables |
|----------|-----------|
| Study | Author, Year, Country, Design |
| Population | N, Age, Sex, Diagnosis criteria |
| Intervention | Type, Dose, Duration, Comparator |
| Outcome | Definition, Timing, Effect size |
| Quality | Risk of bias items |

### Extraction Process | æ“·å–æµç¨‹
- **Extractor(s)**: 
- **Verification**: [Dual extraction / Single + verification]

---

## ğŸ“ Risk of Bias Assessment | åå·®é¢¨éšªè©•ä¼° âš ï¸ REQUIRED

### Tool Selection | å·¥å…·é¸æ“‡
- [ ] RoB 2 (for RCTs)
- [ ] ROBINS-I (for non-randomized studies)
- [ ] Newcastle-Ottawa Scale
- [ ] Other: 

### Domains to Assess | è©•ä¼°é¢å‘
1. 
2. 
3. 

---

## ğŸ“ Statistical Analysis Plan | çµ±è¨ˆåˆ†æè¨ˆç•« âš ï¸ REQUIRED

### Effect Measure | æ•ˆæ‡‰é‡æŒ‡æ¨™
- [ ] Odds Ratio (OR)
- [ ] Risk Ratio (RR)
- [ ] Mean Difference (MD)
- [ ] Standardized Mean Difference (SMD)
- [ ] Hazard Ratio (HR)

### Heterogeneity Assessment | ç•°è³ªæ€§è©•ä¼°
- IÂ² statistic interpretation:
  - 0-25%: Low
  - 25-50%: Moderate
  - 50-75%: Substantial
  - >75%: Considerable
- Cochran's Q test
- Prediction interval

### Meta-analysis Model | çµ±åˆåˆ†ææ¨¡å‹
- [ ] Fixed-effect (Mantel-Haenszel / Inverse variance)
- [ ] Random-effects (DerSimonian-Laird / REML)
- Justification: 

### Subgroup Analyses | æ¬¡ç¾¤çµ„åˆ†æ
1. 
2. 
3. 

### Sensitivity Analyses | æ•æ„Ÿåº¦åˆ†æ
1. Excluding high risk of bias studies
2. 
3. 

### Publication Bias | ç™¼è¡¨åå·®
- [ ] Funnel plot
- [ ] Egger's test
- [ ] Trim-and-fill

---

## ğŸ“ Certainty of Evidence | è­‰æ“šç¢ºå®šæ€§

### GRADE Assessment | GRADE è©•ä¼°
- [ ] Risk of bias
- [ ] Inconsistency
- [ ] Indirectness
- [ ] Imprecision
- [ ] Publication bias

### Summary of Findings Table | çµæœæ‘˜è¦è¡¨
> [Will be generated after analysis]

---

## ğŸ“ PROSPERO Registration | PROSPERO è¨»å†Š âš ï¸ REQUIRED

- **Registration Status**: [Submitted / Registered / Not applicable]
- **Registration Number**: CRD
- **Registration Date**: 

---

## ğŸ“ Software | è»Ÿé«”å·¥å…·

- **Reference management**: [EndNote / Zotero / Mendeley]
- **Screening**: [Covidence / Rayyan / Excel]
- **Meta-analysis**: [RevMan / R meta package / Stata]
- **GRADE**: [GRADEpro]
